Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 17438169)

1.

Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005.

Vagefi PA, Razo O, Deshpande V, McGrath DJ, Lauwers GY, Thayer SP, Warshaw AL, Fernández-Del Castillo C.

Arch Surg. 2007 Apr;142(4):347-54.

2.

Resection of pancreatic neuroendocrine tumors: results of 70 cases.

Kazanjian KK, Reber HA, Hines OJ.

Arch Surg. 2006 Aug;141(8):765-9; discussion 769-70.

PMID:
16924083
3.

Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes.

Haynes AB, Deshpande V, Ingkakul T, Vagefi PA, Szymonifka J, Thayer SP, Ferrone CR, Wargo JA, Warshaw AL, Fernández-del Castillo C.

Arch Surg. 2011 May;146(5):534-8. doi: 10.1001/archsurg.2011.102.

4.

Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?

Fernández-Cruz L, Blanco L, Cosa R, Rendón H.

World J Surg. 2008 May;32(5):904-17. doi: 10.1007/s00268-008-9467-2.

PMID:
18264824
5.

Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.

Matthews BD, Heniford BT, Reardon PR, Brunicardi FC, Greene FL.

Am Surg. 2000 Dec;66(12):1116-22; discussion 1122-3.

PMID:
11149582
6.

Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1.

Lopez CL, Waldmann J, Fendrich V, Langer P, Kann PH, Bartsch DK.

Langenbecks Arch Surg. 2011 Dec;396(8):1187-96. doi: 10.1007/s00423-011-0828-1. Epub 2011 Jul 30.

PMID:
21805182
7.

Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital.

Nikfarjam M, Warshaw AL, Axelrod L, Deshpande V, Thayer SP, Ferrone CR, Fernández-del Castillo C.

Ann Surg. 2008 Jan;247(1):165-72.

8.

Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients.

Phan GQ, Yeo CJ, Hruban RH, Lillemoe KD, Pitt HA, Cameron JL.

J Gastrointest Surg. 1998 Sep-Oct;2(5):472-82.

PMID:
9843608
9.

Central pancreatectomy: single-center experience of 50 cases.

Adham M, Giunippero A, Hervieu V, Courbière M, Partensky C.

Arch Surg. 2008 Feb;143(2):175-80; discussion 180-1. doi: 10.1001/archsurg.2007.52.

PMID:
18283143
10.

Enucleation and limited pancreatic resection provide long-term cure for insulinoma in multiple endocrine neoplasia type 1.

Bartsch DK, Albers M, Knoop R, Kann PH, Fendrich V, Waldmann J.

Neuroendocrinology. 2013;98(4):290-8. doi: 10.1159/000357779. Epub 2013 Dec 17.

11.

Middle pancreatectomy: indications, short- and long-term operative outcomes.

Crippa S, Bassi C, Warshaw AL, Falconi M, Partelli S, Thayer SP, Pederzoli P, Fernández-del Castillo C.

Ann Surg. 2007 Jul;246(1):69-76.

12.

Resection strategies for neuroendocrine pancreatic neoplasms.

Watzka FM, Laumen C, Fottner C, Weber MM, Schad A, Lang H, Musholt TJ.

Langenbecks Arch Surg. 2013 Mar;398(3):431-40. doi: 10.1007/s00423-012-1024-7. Epub 2012 Nov 11.

PMID:
23143147
13.

Parenchyma-sparing resections for pancreatic neuroendocrine tumors.

Cherif R, Gaujoux S, Couvelard A, Dokmak S, Vuillerme MP, Ruszniewski P, Belghiti J, Sauvanet A.

J Gastrointest Surg. 2012 Nov;16(11):2045-55. doi: 10.1007/s11605-012-2002-7. Epub 2012 Aug 22.

PMID:
22911124
14.

Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.

Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT.

Arch Surg. 2003 Aug;138(8):859-66.

PMID:
12912744
15.

Pancreatic cystic endocrine tumors: a different morphological entity associated with a less aggressive behavior.

Boninsegna L, Partelli S, D'Innocenzio MM, Capelli P, Scarpa A, Bassi C, Pederzoli P, Falconi M.

Neuroendocrinology. 2010;92(4):246-51. doi: 10.1159/000318771. Epub 2010 Aug 5.

PMID:
20689265
16.

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, Sauter PK, Coleman J, Hruban RH, Lillemoe KD.

J Gastrointest Surg. 2000 Nov-Dec;4(6):567-79.

PMID:
11307091
17.

Pancreatic neuroendocrine tumors: presentation, management, and outcomes.

Nissen NN, Kim AS, Yu R, Wolin EM, Friedman ML, Lo SK, Wachsman AM, Colquhoun SD.

Am Surg. 2009 Oct;75(10):1025-9.

PMID:
19886158
18.

Middle segmental pancreatectomy: a safe and organ-preserving option for benign and low-grade malignant lesions.

Du ZY, Chen S, Han BS, Shen BY, Liu YB, Peng CH.

World J Gastroenterol. 2013 Mar 7;19(9):1458-65. doi: 10.3748/wjg.v19.i9.1458.

19.

Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors.

Dralle H, Krohn SL, Karges W, Boehm BO, Brauckhoff M, Gimm O.

World J Surg. 2004 Dec;28(12):1248-60. Epub 2004 Nov 11. Review.

PMID:
15517487
20.

Reappraisal of central pancreatectomy a 12-year single-center experience.

Goudard Y, Gaujoux S, Dokmak S, Cros J, Couvelard A, Palazzo M, Ronot M, Vullierme MP, Ruszniewski P, Belghiti J, Sauvanet A.

JAMA Surg. 2014 Apr;149(4):356-63. doi: 10.1001/jamasurg.2013.4146. Erratum in: JAMA Surg. 2014 May;149(5):421.

PMID:
24740703
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk